1.
Patra, A. K.
et al. An alternative NFAT-activation pathway mediated by IL-7 is critical for early thymocyte development.
Nat Immunol 14, 127–135 (2013).
(Article).
2.
Hock, M.
et al. NFATc1 induction in peripheral T and B lymphocytes.
J. Immunol. 190, 2345–2353 (2013).
(Article).
3.
Bhattacharyya, S.
et al. NFATc1 affects mouse splenic B cell function by controlling the calcineurin-NFAT signaling network.
J. Exp. Med. 208, 823–839 (2011).
(Article).
4.
Nayak, A.
et al. Sumoylation of the Transcription Factor NFATc1 Leads to Its Subnuclear Relocalization and Interleukin-2 Repression by Histone Deacetylase.
J. Biol. Chem. 284, 10935–10946 (2009).
(Article).
5.
Silbermann, K., Schneider, G. & Grassmann, R. Stimulation of interleukin-13 expression by human T-cell leukemia virus type 1 oncoprotein Tax via a dually active promoter element responsive to NF-κB and NFAT.
J Gen Virol 89, 2788–2798 (2008).
(Article).
6.
Klein-Hessling, S.
et al. Cyclic AMP-induced Chromatin Changes Support the NFATc-mediated Recruitment of GATA-3 to the Interleukin 5 Promoter.
J. Biol. Chem. 283, 31030–31037 (2008).
(Article).
7.
Akimzhanov, A.
et al. Epigenetic Changes and Suppression of the Nuclear Factor of Activated T Cell 1 (NFATC1) Promoter in Human Lymphomas with Defects in Immunoreceptor Signaling.
Am J Pathol 172, 215–224 (2008).
(Article).
8.
Klein, M.
et al. Specific and Redundant Roles for NFAT Transcription Factors in the Expression of Mast Cell-Derived Cytokines.
J Immunol 177, 6667–6674 (2006).
(Article).
9.
Glazova, M.
et al. Pim-1 kinase enhances NFATc activity and neuroendocrine functions in PC12 cells.
Brain Res. Mol. Brain Res. 138, 116–123 (2005).
(Article).